Dual-mechanism anti-CD73 antibodies CR201 and CR202 targeting distinct domains for cancer immunotherapy - Top-Institutions - MDSpire

Dual-mechanism anti-CD73 antibodies CR201 and CR202 targeting distinct domains for cancer immunotherapy

  • By

  • Miao Zhang

  • Haibin Yuan

  • Xindi Pan

  • Xian Li

  • Zichen Wang

  • Shuping Zhang

  • Zhigang Gu

  • Biao Hu

  • Xuedong Qu

  • Qian Wang

  • Xiangguo Gu

  • Bo Wang

  • Yu Cao

  • Guilin Mu

  • Guangbo Kang

  • Ario de Marco

  • Xiangshan Zhou

  • He Huang

  • June 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Tianjin University
    Tianjin University

    Tianjin, China

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #2

    China Resources Biopharmaceutical Co., Ltd.
    China Resources Biopharmaceutical Co., Ltd.

    Beijing, China

    Key Differentiators

    • Biopharmaceuticals
    • Oncology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #4

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, France

    Key Differentiators

    • Oncology

  • #5

    Fred Hutchinson Cancer Research Center
    Fred Hutchinson Cancer Research Center

    Seattle, Washington

    Key Differentiators

    • Cancer Research

Original Source(s)

Dual-mechanism anti-CD73 antibodies CR201 and CR202 targeting distinct domains for cancer immunotherapy

  • by Miao Zhang, Haibin Yuan, Xindi Pan, Xian Li, Zichen Wang, Shuping Zhang, Zhigang Gu, Biao Hu, Xuedong Qu, Qian Wang, Xiangguo Gu, Bo Wang, Yu Cao, Guilin Mu, Guangbo Kang, Ario de Marco, Xiangshan Zhou, He Huang

  • June 10, 2026

Related Content

Early risk stratification and temporal biomarker patterns of trousseau syndrome-related cerebral infarction in lung cancer

Long-term results after surgical resection of intrahepatic cholangiocarcinoma before and since the BILCAP era

Multimodal treatment and long-term survival in a rare case of melanoma with pancreatic and splenic metastases: a case report and literature review